Gene Therapy for Metachromatic Leukodystrophy (MLD)

Clinical trial NCT01560182 · COMPLETED

Trial details

NCT number: NCT01560182
Sponsor: Orchard Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lysosomal Storage Disease Metachromatic Leukodystrophy

Start date: 2010-04-09
Primary completion: 2018-04-09
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.